Review paper

Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic Diseases

Volume: 20, Issue: 10, Pages: 1068 - 1080
Published: Jul 12, 2019
Abstract
Toll-like receptors (TLR) are one among the initial responders of the immune system which participate in the activation inflammatory processes. Several different types of TLR such as TLR2, TLR4, TLR7 and TLR9 have been identified in various cell types, each having distinct ligands like lipids, lipoproteins, nucleic acids and proteins. Though its prime concern is xenobiotic defences, TLR signalling has also recognized as an activator of...
Paper Details
Title
Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic Diseases
Published Date
Jul 12, 2019
Volume
20
Issue
10
Pages
1068 - 1080
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.